Ocumension Therapeutics(HK:1477)
HK$4.96-0.21 (-4.07%)
HK:1477
Ocumension Therapeutics ownership
HK$4.96
At close:-0.21 (-4.07%)
Want to see HK:1477 full AI Analyst Report?
Ocumension Therapeutics (1477) Ownership - Who Owns Ocumension Therapeutics?
2 Followers
Ocumension Therapeutics (1477) Ownership Overview
- 1.48% Mutual Funds
- 1.52% ETFs
- 97.00% Public Companies and Individual Investors
The ownership structure of Ocumension Therapeutics (HK:1477) stock is a mix of institutional, retail, and individual investors. Approximately 3.00% of the company’s stock is owned by Institutional Investors, and 97.00% is owned by Public Companies and Individual Investors.
The ownership structure of Ocumension Therapeutics (HK:1477) stock is a mix of institutional, retail, and individual investors. Approximately 3.00% of the company’s stock is owned by Institutional Investors, and 97.00% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 10,914,740 | Institution | 1.31% | 6,887,201 |
| Vanguard International Equity Index Funds | 6,090,715 | Institution | 0.73% | 3,843,241 |
| Vanguard Star Funds | 4,736,327 | Institution | 0.57% | 2,988,622 |
| Dfa Investment Dimensions Group Inc | 1,586,000 | Institution | 0.19% | 1,000,766 |
| Ishares | 813,500 | Institution | 0.10% | 513,319 |
| Dimensional | 568,500 | Institution | 0.07% | 358,724 |
| Spdr | 247,500 | Institution | 0.03% | 156,173 |
| State Street | 136,000 | Institution | 0.02% | 85,816 |
| Hsbc | 24,250 | Institution | <0.01% | 15,302 |
| Avantis | 13,500 | Institution | <0.01% | 8,519 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard International Equity Index Funds | 6,090,715 | Institution | 0.73% | 3,843,241 |
| Vanguard Star Funds | 4,736,327 | Institution | 0.57% | 2,988,622 |
| Dfa Investment Dimensions Group Inc | 1,586,000 | Institution | 0.19% | 1,000,766 |
| Franklin Alternative Strategies Funds | 2 | Institution | 0.00% | 1 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Total International Stock ETF, VXUS ETF | 4,736,327 | Institution | 0.57% | 3,062,413 |
| Vanguard FTSE Emerging Markets ETF, VWO ETF | 4,583,215 | Institution | 0.55% | 2,963,414 |
| Vanguard FTSE All-World ex-US Small-Cap ETF, VSS ETF | 1,329,500 | Institution | 0.16% | 859,627 |
| Dimensional Emerging Core Equity Market ETF, DFAE ETF | 241,000 | Institution | 0.03% | 158,670 |
| iShares MSCI EM IMI ESG Screened UCITS ETF, GB:SEDM ETF | 198,500 | Institution | 0.02% | 128,084 |
| Vanguard Total World Stock ETF, VT ETF | 188,000 | Institution | 0.02% | 121,557 |
| Dimensional Emerging Markets Core Equity 2 ETF, DFEM ETF | 183,000 | Institution | 0.02% | 120,484 |
| Dimensional World ex U.S. Core Equity 2 ETF, DFAX ETF | 144,500 | Institution | 0.02% | 95,136 |
| iShares MSCI China Small-Cap ETF, ECNS ETF | 112,500 | Institution | 0.01% | 71,058 |
| iShares MSCI Emerging Markets Small Cap ETF, EEMS ETF | 104,000 | Institution | 0.01% | 65,689 |
FAQ
What percentage of Ocumension Therapeutics (HK:1477) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.00% of Ocumension Therapeutics (HK:1477) stock is held by institutional investors: 1.48% by mutual funds and 1.52% by ETFs.
What percentage of Ocumension Therapeutics (HK:1477) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.00% of Ocumension Therapeutics (HK:1477) stock is held by public companies and individual investors.
Who owns the most shares of Ocumension Therapeutics (HK:1477)?
Vanguard owns the most shares of Ocumension Therapeutics (HK:1477).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
